Share on LinkedInShare on LinkedIn

ARTICLE · 23 JUNE 2015

Is Legislative Reform For Inter Partes Review On The Horizon?

Less than three years after implementation of the Inter Partes Review process, the life science industry is already calling upon Congress for significant reform.

United StatesIntellectual Property

Less than three years after implementation of the Inter Partes Review process, the life science industry is already calling upon Congress for significant reform.

When the Leahy-Smith America Invents Act ("AIA") was signed into law on September 16, 2011, it resulted in substantial changes to the United States patent system. Among the changes was the introduction of a new post-grant proceeding, inter partes review ("IPR"),1 and the creation of the tribunal responsible for conducting these proceedings, the Patent Trial and Appeal Board ("PTAB").2 The IPR procedure allows a party to challenge the patentability of a patent as anticipated (35 U.S.C. § 102) or obvious (§ 103) based on prior-art patents and printed publications.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from